Background: As a core member of the FA complex, in the Fanconi anemia pathway, FAAP24 plays an important role in DNA damage repair. However, the association between FAAP24 and patient prognosis in AML and immune infiltration remains unclear. The purpose of this study was to explore its expression characteristics, immune infiltration pattern, prognostic value and biological function using TCGA-AML and to verify it in the Beat AML cohort.
Methods: In this study, we examined the expression and prognostic value of FAAP24 across cancers using data from TCGA, TARGET, GTEx, and GEPIA2. To further investigate the prognosis in AML, development and validation of a nomogram containing FAAP24 were performed. GO/KEGG, ssGSEA, GSVA and xCell were utilized to explore the functional enrichment and immunological features of FAAP24 in AML. Drug sensitivity analysis used data from the CellMiner website, and the results were confirmed in vitro.
Results: Integrated analysis of the TCGA, TARGET and GTEx databases showed that FAAP24 is upregulated in AML; meanwhile, high FAAP24 expression was associated with poor prognosis according to GEPIA2. Gene set enrichment analysis revealed that FAAP24 is implicated in pathways involved in DNA damage repair, the cell cycle and cancer. Components of the immune microenvironment using xCell indicate that FAAP24 shapes an immunosuppressive tumor microenvironment (TME) in AML, which helps to promote AML progression. Drug sensitivity analysis showed a significant correlation between high FAAP24 expression and chelerythrine resistance. In conclusion, FAAP24 could serve as a novel prognostic biomarker and play an immunomodulatory role in AML.
Conclusions: In summary, FAAP24 is a promising prognostic biomarker in AML that requires further exploration and confirmation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276373 | PMC |
| http://dx.doi.org/10.1186/s12935-023-02937-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers.
Int J Cancer
December 2024
Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
A double primary colorectal cancer (CRC) in a familial setting signals a high risk of CRC. In order to identify novel CRC susceptibility genes, we whole-exome sequenced germline DNA from nine persons with a double primary CRC and a family history of CRC. The detected variants were processed by bioinformatics filtering and prioritization, including STRING protein-protein interaction and pathway analysis.
View Article and Find Full Text PDFHigh FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML.
Cancer Cell Int
June 2023
Suzhou Key Laboratory of Medical Biotechnology, Suzhou Vocational Health College, 28 Kehua Road, Suzhou, 215009, China.
Background: As a core member of the FA complex, in the Fanconi anemia pathway, FAAP24 plays an important role in DNA damage repair. However, the association between FAAP24 and patient prognosis in AML and immune infiltration remains unclear. The purpose of this study was to explore its expression characteristics, immune infiltration pattern, prognostic value and biological function using TCGA-AML and to verify it in the Beat AML cohort.
View Article and Find Full Text PDFSomatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing.
Anticancer Res
May 2023
Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark;
Article Synopsis
- This study explores the role of various DNA-damage response (DDR) genes beyond BRCA1/2 in ovarian cancer treatment, specifically focusing on poly(ADP-ribose) polymerase inhibitors (PARPi).
- Whole-exome sequencing of patients with high-grade serous adenocarcinoma and clear cell carcinoma revealed 42 genetic variants across 28 DDR genes, highlighting the complexity of genetic alterations in ovarian cancer.
- The findings suggest these variants may serve as biomarkers to predict response to treatments and could improve understanding of disease progression based on disrupted DDR pathways.
Structure analysis of FAAP24 reveals single-stranded DNA-binding activity and domain functions in DNA damage response.
Cell Res
October 2013
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The FANCM/FAAP24 heterodimer has distinct functions in protecting cells from complex DNA lesions such as interstrand crosslinks. These functions rely on the biochemical activity of FANCM/FAAP24 to recognize and bind to damaged DNA or stalled replication forks. However, the DNA-binding activity of this complex was not clearly defined.
View Article and Find Full Text PDFThe Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks.
Mol Cell
January 2008
Department of Biochemistry, University of Lausanne, Ch. des Boveresses 155, 1066 Epalinges s/Lausanne, Switzerland.
Fanconi anemia (FA) is a genetically heterogeneous cancer-prone disorder associated with chromosomal instability and cellular hypersensitivity to DNA crosslinking agents. The FA pathway is suspected to play a crucial role in the cellular response to DNA replication stress. At a molecular level, however, the function of most of the FA proteins is unknown.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!